Charles Zhu

Stock Analyst at LifeSci Capital

(2.02)
# 1228
Out of 5,386 analysts
27
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
12 Stocks
Name Action PT Current % Upside Ratings Updated
CBIO Crescent Biopharma
Initiates Coverage On: Outperform
22
15.97 37.76% 1 Jun 18, 2025
RPTX Repare Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Dec 13, 2024
TNGX Tango Therapeutics
Maintains: Buy
18 8
5 60% 3 Nov 7, 2024
MGNX Macrogenics
Upgrades: Buy
12
1.21 891.74% 4 Nov 7, 2023
MRUS Merus
Maintains: Strong Buy
46 48
52.94 -9.33% 6 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
56
79.64 -29.68% 1 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
22
2.88 663.89% 1 Jul 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26
7.11 265.68% 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32
21.39 49.6% 3 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
14
12.45 12.45% 2 May 5, 2022